Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.

Tomasz Sablinski(Icahn School of Medicine at Mount Sinai), Kupiec-Weglinski Jw, Milford El, Kut Jp, Tilney Nl, Hancock Ww, Mohamed H. Sayegh(American University of Beirut)

PubMed

February 1, 1991

Cited by 0

Related Papers

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

|Nature Medicine|2007|2.2k

Immunomodulation by Mesenchymal Stem Cells

|Diabetes|2008|470

EFFECTS OF EXPLOSIVE BRAIN DEATH ON CYTOKINE ACTIVATION OF PERIPHERAL ORGANS IN THE RAT1

|Transplantation|1998|404

Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes

|The Journal of Immunology|2009|383

Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance

|The Journal of Experimental Medicine|1998|340